Trials / Completed
CompletedNCT03370380
Aflibercept in Patients With Pigment Epithelial Detachments (PED)
Intravitreal Aflibercept in Patients With Retinal Pigment Epithelial Detachment (PED) Secondary to Age Related Macular Degeneration (AMD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- University Hospital Muenster · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- —
Summary
Uncontrolled single site non randomized non interventional study to determine the safety and efficacy of intravitreal injections of Aflibercept in patients with recent vision loss due to retinal pigment epithelial detachment secondary to AMD
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aflibercept | Patients are treated according to authorization of Aflibercept |
Timeline
- Start date
- 2015-04-17
- Primary completion
- 2018-04-23
- Completion
- 2018-04-23
- First posted
- 2017-12-12
- Last updated
- 2018-08-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03370380. Inclusion in this directory is not an endorsement.